Search the Newsreel

California State Teachers Retirement System Has $5.70 Million Holdings in Enphase Energy, Inc. $ENPH

The California State Teachers Retirement System increased its stake in Enphase Energy (NASDAQ:ENPH) by 21.6% to 150,840 shares, valued at $5.70 million. Despite this, the company's stock has shown mixed performance, opening at $39.67, below its 50-day moving average, and its recent quarterly EPS …

JPMorgan Chase & Co. Issues Positive Forecast for easyJet (LON:EZJ) Stock Price

JPMorgan Chase & Co. has increased its price target for easyJet (LON:EZJ) from GBX 360 to GBX 715, maintaining a "neutral" rating and suggesting a potential upside of 7.13%. Other analysts have offered varied ratings, with the consensus being "Hold" and a target price …

Enphase Stock Faces A New US Tariff Test In Polysilicon

The US has imposed new 15% tariffs and price floors on polysilicon imports, impacting solar and semiconductor supply chains. This article examines three companies: Enphase Energy, which faces rising input costs and potential demand softening; REC Silicon, a US-based polysilicon producer that could benefit …

REG - Bytes Technology Grp JPMorgan Chase & Co - Holding(s) in Company

JPMorgan Chase & Co. has notified Bytes Technology Group PLC of a change in its major holdings. As of August 4, 2026, JPMorgan Chase & Co. holds a total of 5.387578% of voting rights in Bytes Technology Group PLC, comprising 0.398115% directly attached to …

ENPH Stock Slips After Hours As Earnings Weighed Down By Federal Tax Credit Expiry

Amphastar P earnings beat by $0.28, revenue topped estimates

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals reported a 5% year-over-year revenue increase in Q2 2026, reaching $183.9 million, driven by new product launches like ipratropium bromide inhalation. Despite a slight dip in net income, diluted EPS rose, and the company is addressing an FDA warning letter at its …

Amphastar anticipates $2M-$3M per quarter IMS remediation costs while maintaining mid-single digit to high single-digit 2026 sales growth

Earnings Call Insights: Amphastar Pharmaceuticals (AMPH) Q2 2026 MANAGEMENT VIEW * “The second quarter was marked by strong execution across each of our strategic growth pillars.” (Senior Vice President of Human Resources & Corporate Communication Dan Dischner) * “Revenue increased to approximately $184 million, …

Earnings call transcript: Amphastar rises after q2 2026 revenue beat

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

JPMorgan Chase & Co. Boosts Corpay (NYSE:CPAY) Price Target to $470.00

JPMorgan Chase & Co. has increased its price target for Corpay (NYSE:CPAY) to $470.00 from $400.00, maintaining an "overweight" rating. This upgrade follows Corpay's strong second-quarter earnings, which surpassed analyst expectations for both EPS and revenue, and the company's raised guidance for Q3 and …

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported better-than-expected Q2 CY2026 results, with revenue of $183.9 million exceeding analyst estimates by 2% and non-GAAP profit of $0.91 per share significantly beating consensus estimates. The company achieved 5.4% year-on-year revenue growth and highlighted successful key goals including overall revenue …

Amphastar Pharmaceuticals (NASDAQ: AMPH) Q2 revenue rises 5% with margin gains

Amphastar Pharmaceuticals reported a 5% increase in Q2 2026 net revenues to $183.9 million, driven by growth in new products like Ipratropium bromide, despite declines in others such as BAQSIMI and Glucagon. The company achieved a gross margin expansion to 50.8%, although GAAP net …

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Amphastar Pharmaceuticals, Inc. reported net revenues of $183.9 million for the second quarter of 2026, marking a 5% increase year-over-year. GAAP net income was $30.3 million ($0.67 per share), while adjusted non-GAAP net income reached $40.8 million ($0.91 per share). The company highlighted continued …

Capital One dismissal bid puts Trump's JPMorgan Chase "political debanking" lawsuit in sharper focus

A new filing by Capital One, seeking to dismiss a lawsuit from Donald Trump's businesses alleging political discrimination for closing over 300 accounts, is drawing attention to a similar, larger lawsuit against JPMorgan Chase. Both cases challenge whether banks improperly used their broad authority …

JPMorgan CEO Leads 40-Company Effort to Tackle AI Risks

JPMorgan Chase CEO Jamie Dimon is leading an initiative involving over 40 companies across critical infrastructure sectors to address the growing risks posed by advanced AI systems. This effort builds on the existing Alliance for Critical Infrastructure (ACI), co-founded by JPMorgan Chase, which aims …

Hasbro now has a new favorite child thanks to Marvel: Magic: The Gathering (sorry Transformers, Monopoly, and NERF!)

Hasbro reported a successful fiscal quarter, largely driven by the exceptional performance of Magic: The Gathering. The game's revenue increased by 34% over the past year, with its recent Marvel Super Heroes crossover set achieving record-breaking sales. This success, along with other sets like …

Pacer Advisors Inc. Buys 83,739 Shares of Amphastar Pharmaceuticals, Inc. $AMPH

Pacer Advisors Inc. increased its stake in Amphastar Pharmaceuticals by 47.1% in the first quarter, purchasing 83,739 additional shares, bringing its total holdings to 261,483 shares valued at approximately $5.1 million. Despite this institutional interest, analyst sentiment remains cautious with a "Reduce" consensus rating …

QUICK SPARK: JPMorgan's New JLVP ETF Can Bet Both for and Against Stocks

JPMorgan Asset Management has launched the JPMorgan US Large Cap Value Plus ETF (JLVP), an actively managed extension strategy that allows the fund to bet both for and against stocks. This ETF combines a traditional U.S. large-cap portfolio with a limited short book, enabling …

JPMorgan's Dimon leads industry group to target AI risks - report (JPM:NYSE)

Jamie Dimon, Chairman and CEO of JPMorgan Chase, is reportedly leading a U.S. cross-industry initiative aimed at addressing the risks associated with artificial intelligence. This effort comes as American corporations increasingly adopt AI technologies. Dimon has personally reached out to various CEOs to engage …

JPMorgan Warns HYPE Could Lose Ground to SOL, XRP as ETF Inflows Stall

JPMorgan has issued a warning that Hyperliquid (HYPE) could lose market share to Solana (SOL) and XRP as its ETF inflows have stalled after a strong performance in May and June. The bank identifies two main threats: the rise of regulated U.S. crypto perpetual …

JPMorgan Chase (NYSE: JPM) posts $57.3B Q2 revenue and $21.2B profit

Amphastar Pharmaceuticals (AMPH) Earnings Date and Reports 2026

Enphase Energy (ENPH) Is Up 15.0% After Pivoting Q3 Outlook Toward U.S.-Made AI Power Electronics – Has The Bull Case Changed?

Enphase Energy (ENPH) saw its stock rise 15% after shifting its Q3 outlook to emphasize U.S.-made AI power electronics, aligning with federal incentives and targeting AI data center demand. Despite recent declines in sales and earnings, the company is focusing on new U.S. manufacturing …

JPMorgan's Jamie Dimon warns of high leverage: 'Somebody will disrupt the market'

JPMorgan CEO Jamie Dimon warns that high leverage across financial markets, including hidden forms beyond traditional margin debt, increases the risk of market disruptions. While not deeming it a systemic threat akin to 2008, he highlights that such leverage makes markets more vulnerable to …

JPMorgan Chase hires Lissauer for activism defense

JPMorgan Chase has hired Amy Lissauer from Bank of America to lead its global shareholder engagement practice, aiming to strengthen its activism defense services. Lissauer, a seasoned advisor in dealing with activist investors, will join as the global head of Shareholder Engagement and M&A …

JPMorgan poaches M&A banker Amy Lissauer from Bank of America

JPMorgan Chase has hired star investment banker Amy Lissauer from Bank of America to lead its activism defense practice. This strategic move aims to bolster JPMorgan's M&A market share and enhance its ability to advise companies against hostile investors, amidst a broader reorganization within …

JPMorgan Adjusts Price Target on Emerson Electric to $169 From $157

JPMorgan has adjusted its price target for Emerson Electric (EMR) to $169, an increase from its previous target of $157. This change was published on August 5, 2026, at 11:56 am EDT by MT Newswires. Other financial institutions like Jefferies, Baird, Evercore ISI, Citigroup, …

Hasbro, Inc. $HAS Shares Bought by Empowered Funds LLC

Empowered Funds LLC significantly increased its stake in Hasbro, Inc. (NASDAQ:HAS) by 80.7% in the first quarter, now owning 31,625 shares valued at $2.96 million. Other institutional investors like Vanguard Group Inc. and State Street Corp also adjusted their positions. The article details Hasbro's …

Enphase Energy expands US manufacturing for power electronics By Investing.com

Enphase Energy is expanding its U.S. manufacturing of power electronics for residential, commercial solar, battery systems, and AI data center infrastructure. The company, which already produces IQ Microinverters and IQ Batteries in South Carolina and Texas, plans to domestically manufacture its upcoming IQ Solid-State …

A 1 GW AI Data Center Could Need Roughly 250,000 IQ SST Modules

Enphase Energy has reaffirmed its commitment to U.S. design and manufacturing for critical power electronics, including residential, commercial, and AI data center infrastructure components. The company currently produces IQ Microinverters and IQ Batteries in South Carolina and Texas and plans to manufacture its new …

Enphase Energy Reinforces U.S. Manufacturing Across Residential, Commercial, and AI Infrastructure

Enphase Energy, Inc. IQ Microinverters, IQ Batteries, and the upcoming IQ Solid-State Transformer platform bring trusted U.S. power electronics to homes, businesses, and AI data centers FREMONT, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, …

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 8.80% Upside Potential

Amphastar Pharmaceuticals (NASDAQ: AMPH) is a biopharmaceutical company with a diverse product portfolio showing an 8.80% upside potential from its current stock price of $20.22, with an average target price of $22.00. Despite its strong free cash flow and return on equity, caution is …

Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Amphastar Pharmaceuticals (NASDAQ:AMPH) by 12.7% in the first quarter, now owning over 2 million shares. Despite this institutional interest, Amphastar's recent quarterly earnings missed analyst expectations for both EPS and revenue, contributing to a "Reduce" …

Hasbro, Inc. $HAS Stock Holdings Lifted by Royal Bank of Canada

Royal Bank of Canada significantly increased its stake in Hasbro, Inc. (NASDAQ:HAS) by 50.3% in the first quarter, bringing its total holdings to 402,365 shares valued at approximately $37.7 million. Several other institutional investors also raised their positions, indicating strong institutional confidence, with institutions …

Edgestream Partners L.P. Trims Stake in Hasbro, Inc. $HAS

Edgestream Partners L.P. significantly reduced its stake in Hasbro, Inc. (NASDAQ:HAS) by 68.6% during the first quarter, selling over 41,000 shares. Despite this, other hedge funds increased their positions, and institutional investors own a substantial portion of the company. The article also covers recent …